Invention Grant
- Patent Title: Poxviral vaccines
-
Application No.: US16782268Application Date: 2020-02-05
-
Publication No.: US11278614B2Publication Date: 2022-03-22
- Inventor: Stefano Colloca , Riccardo Cortese , Antonella Folgori , Alfredo Nicosia
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: WOPCT/EP2013/055409 20130315
- Main IPC: C12N15/863
- IPC: C12N15/863 ; A61K39/00 ; C07K14/74 ; C07K14/005 ; A61K39/29 ; C12N7/00 ; C12N15/86
Abstract:
The present application relates to novel administration regimens for poxviral vectors comprising nucleic acid constructs encoding antigenic proteins and invariant chains. In particular the use of said poxviral vectors for priming or for boosting an immune response is disclosed.
Public/Granted literature
- US20200164061A1 POXVIRAL VACCINES Public/Granted day:2020-05-28
Information query
IPC分类:
